Business
The company plans to use the new funds to launch its Stim Assist and its Alife mobile app.
The app includes an AI software algorithm, which was cleared in 2020.
Also: Telehealth startup Antidote Health and fertility tech company Alife Health both raise $22 million.
The device, which is not yet cleared by the FDA, alerts bystanders to a potential cardiac event nearby and guides them to the scene.
The company plans to use the money to build out its care coordination staff as well as its sales and marketing teams.
As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.
Also, Israeli startup Well-Beat teams with UST to launch digital patient engagement solution.
The firm scored €500M in equity, debt funding.
HIMSS22
During a session at HIMSS22, panelists discussed how provider-based venture capital firms, accelerators and incubators can help digital health startups understand and collaborate with the larger healthcare industry.
The publicly listed firm continues its expansion into digital health.